BIOMAT Database Logo BIOMAT Database Logo

A potent inhibitor of thromboxane A2 biosynthesis in aggregating human blood platelets. 1977

R J Gryglewski, and A Zmuda, and A Dembińska-Kieć, and E Krecioch

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011714 Pyrans Pyran
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D005260 Female Females

Related Publications

R J Gryglewski, and A Zmuda, and A Dembińska-Kieć, and E Krecioch
Inhibition of thromboxane A2 biosynthesis in human platelets by burimamide.
January 1980, British journal of pharmacology,
R J Gryglewski, and A Zmuda, and A Dembińska-Kieć, and E Krecioch
Thromboxane a2: biosynthesis and effects on platelets.
January 1982, Advances in prostaglandin, thromboxane, and leukotriene research,
R J Gryglewski, and A Zmuda, and A Dembińska-Kieć, and E Krecioch
Increased biosynthesis of thromboxane A2 by diabetic platelets.
June 1979, European journal of clinical investigation,
R J Gryglewski, and A Zmuda, and A Dembińska-Kieć, and E Krecioch
Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
July 1985, The American journal of physiology,
R J Gryglewski, and A Zmuda, and A Dembińska-Kieć, and E Krecioch
Thromboxane A2 biosynthesis in human disease.
January 1987, Federation proceedings,
R J Gryglewski, and A Zmuda, and A Dembińska-Kieć, and E Krecioch
CV-4151--a potent, selective thromboxane A2 synthetase inhibitor.
January 1986, Thrombosis research,
R J Gryglewski, and A Zmuda, and A Dembińska-Kieć, and E Krecioch
Purification of the thromboxane A2/prostaglandin H2 receptor from human blood platelets.
October 1989, The Journal of biological chemistry,
R J Gryglewski, and A Zmuda, and A Dembińska-Kieć, and E Krecioch
Effects of trapidil on thromboxane A2-induced aggregation of platelets, ischemic changes in heart and biosynthesis of thromboxane A2.
March 1981, Prostaglandins and medicine,
R J Gryglewski, and A Zmuda, and A Dembińska-Kieć, and E Krecioch
A photoaffinity label for the thromboxane A2/prostaglandin H2 receptor in human blood platelets.
March 1987, FEBS letters,
R J Gryglewski, and A Zmuda, and A Dembińska-Kieć, and E Krecioch
Heparin potentiates synthesis of thromboxane A2 in human platelets.
January 1980, Advances in prostaglandin and thromboxane research,
Copied contents to your clipboard!